Efficacy of Vitamin E in Preventing Contrast-Induced Acute Kidney Injury Following Coronary Angiography
NCT02070679 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 284
Last updated 2015-06-16
Summary
The purpose of this study is to evaluate the effect of vitamin E on preventing from incidence of contrast induced acute kidney injury (CI-AKI) in the patients who undergone coronary angiography.
Conditions
- Stable Angina
- Unstable Angina
- Non ST Segment Elevation Myocardial Infarction
- Post MI
Interventions
- DRUG
-
Vitamin E
Sponsors & Collaborators
-
Urmia University of Medical Sciences
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-02-28
- Primary Completion
- 2015-05-31
- Completion
- 2015-06-30
Countries
- Iran
Study Locations
More Related Trials
-
Ameliorating Contrast Induced Nephropathy After Coronary Angiography
NCT06139952 ·Status: COMPLETED ·Phase: PHASE4
-
Using Preprocedural Urine NMR(Nuclear Magnetic Resonance) -Based Metabolomics Analysis
NCT03731962 ·Status: COMPLETED ·Phase: NA
-
Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease
NCT00808795 ·Status: COMPLETED ·Phase: PHASE3
-
Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes
NCT01978405 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy
NCT03391830 ·Status: COMPLETED ·Phase: NA
-
Study of Intravenous Amino Acid Infusion to Prevent Contrast Dye Mediated Renal Damage
NCT00313807 ·Status: WITHDRAWN ·Phase: PHASE2
-
Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by N-Acetylcystein
NCT00463749 ·Status: COMPLETED ·Phase: PHASE3
-
Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease
NCT04163484 ·Status: COMPLETED
-
Theophylline, N-acetylcysteine, and Theophylline Plus N-acetylcysteine in Preventing Contrast-induced Nephropathy
NCT02088502 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Folic Acid for Prevention of Contrast Induced Nephropathy
NCT02444013 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Phentolamine in Prevention of Contrast-Associated Acute Kidney Injury After Complex PCI
NCT06286059 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Prevention of Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions
NCT02468401 ·Status: COMPLETED ·Phase: NA
-
Ischemic Preconditioning to Prevent Acute Kidney Injury
NCT02167152 ·Status: COMPLETED ·Phase: NA
-
Renal PRotection Against Contrast mEdium-induced nephroPathy in High Risk Patients undErgoing Coronary Angiography
NCT02463604 ·Status: COMPLETED ·Phase: NA
-
Prevention of Contrast-Induced Nephropathy in Diabetic Patients With Undergoing Coronary Angiography
NCT00950079 ·Status: UNKNOWN ·Phase: PHASE4
-
Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients
NCT01017796 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Aminophylline and Contrast Induced Nephropathy in Acute Myocardial Infarction
NCT01594489 ·Status: COMPLETED ·Phase: PHASE4
-
The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy
NCT03627130 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction
NCT01160627 ·Status: COMPLETED ·Phase: NA
-
The Effect of Remote Ischemic Preconditioning on Elective Percutaneous Coronary Intervention in Diabetic Nephropathy
NCT02329444 ·Status: COMPLETED ·Phase: NA
-
N-Acetyl Cystein and Contrast Nephropathy
NCT01820195 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy Trial of N-Acetylcysteine and Sodium Bicarbonate for the Prevention of Contrast-Induced Acute Kidney Injury
NCT01210456 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison of Carvedilol and Atorvastatin for Preventing of Contrast-Induced Nephropathy.
NCT03867994 ·Status: COMPLETED ·Phase: PHASE2
-
Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3
NCT05264584 ·Status: COMPLETED ·Phase: NA
-
PROMISS: Simvastatin Prevents the Contrast Induced Acute Renal Failure in Patients With Renal Insufficiency Undergoing Coronary Angiography
NCT00259441 ·Status: COMPLETED ·Phase: PHASE4